Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease.
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...
According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...
A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback